IntegratBioPharma Sub Appoints Head of Operations
Wholly-owned Manhattan Drug Co subsidiary named Michael Richtmyer as Head of Operations. Market relevance: Signals strategic focus on manufacturing scale and operational excellence.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day